Sharekhan is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 1800 in its research report dated August 14, 2019.
Sharekhan's research report on Divi’s Laboratories
Divis Laboratories Limited’s (Divis) quarterly performance was marginally below our expectation. Growth outlook intact, capex to weigh on margins in FY2020, no pending regulatory hurdles. We expect the company to a report sales/profit CAGR of 21%/18% over FY2019-FY2021.
We maintain our Buy rating on the stock with marginally lowered PT of Rs. 1,800.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.